ReviewInternational journal of molecular sciences2021

Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls?

Benoîte Mery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.